BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 12720163)

  • 1. Appropriateness of applying the response criteria for multiple myeloma to Waldenstrom's macroglobulinemia?
    Bladé J; Montoto S; Rosiñol L; Montserrat E
    Semin Oncol; 2003 Apr; 30(2):329-31. PubMed ID: 12720163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uniform response criteria in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Weber D; Treon SP; Emmanouilides C; Branagan AR; Byrd JC; Bladé J; Kimby E
    Semin Oncol; 2003 Apr; 30(2):127-31. PubMed ID: 12720121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of serum viscosity measurements in assessing the response to therapy in myeloma and Waldenström's macroglobulinaemia.
    Kok DA
    Bibl Anat; 1967; 9():252-8. PubMed ID: 4961775
    [No Abstract]   [Full Text] [Related]  

  • 4. Fludarabine therapy in a patient with progressive symptomatic Waldenström's macroglobulinemia.
    Hałaburda K; Hellmann A
    Acta Haematol Pol; 1994; 25(1):63-7. PubMed ID: 8209618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors and response to fludarabine therapy in Waldenstrom's macroglobulinemia: an update of a US intergroup trial (SW0G S9003).
    Dhodapkar MV; Jacobson JL; Gertz MA; Crowley JJ; Barlogie B
    Semin Oncol; 2003 Apr; 30(2):220-5. PubMed ID: 12720140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis and treatment of Waldenström's macroglobulinemia.
    Louw VJ; Webb MJ
    Transfus Apher Sci; 2010 Apr; 42(2):193-7. PubMed ID: 20117052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of Waldenstrom's macroglobulinemia.
    McDermott MK; Bell EM
    Clin J Oncol Nurs; 1999 Jul; 3(3):107-11. PubMed ID: 10690041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Chlorodeoxyadenosine alone and in combination for previously untreated Waldenstrom's macroglobulinemia.
    Weber DM; Dimopoulos MA; Delasalle K; Rankin K; Gavino M; Alexanian R
    Semin Oncol; 2003 Apr; 30(2):243-7. PubMed ID: 12720145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and management of Waldenstrom's macroglobulinemia.
    Dimopoulos MA; Kyle RA; Anagnostopoulos A; Treon SP
    J Clin Oncol; 2005 Mar; 23(7):1564-77. PubMed ID: 15735132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current treatment of Kahler's disease and Waldenström's macroglobulinemia].
    Seligmann M; Meshaka G
    Sem Ther; 1965; 41(6):373-5. PubMed ID: 4964847
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatocellular carcinoma followed by Waldenström's macroglobulinemia: a case report.
    Hasegawa K; Kubota K; Hirai H; Imai Y; Midorikawa Y; Makuuchi M
    Hepatogastroenterology; 2000; 47(33):842-5. PubMed ID: 10919044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyacrylamide electrophoresis. II. Study of serum proteins in multiple myeloma and Waldenstrom's macroglobulinemia.
    Dammacco F; Pinto L
    Riv Ist Sieroter Ital; 1967; 42(1):17-23. PubMed ID: 4970260
    [No Abstract]   [Full Text] [Related]  

  • 13. [Waldenström's macroglobulinemia].
    Meznik A; Steppert A
    Wien Med Wochenschr; 1968 Jun; 118(23):523-31. PubMed ID: 4977674
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thromboplastin formation in Waldenström's macroglobulinemia and in multiple myeloma].
    Zhuravlev VS; Totskaia AA
    Probl Gematol Pereliv Krovi; 1969 Jul; 14(7):27-33. PubMed ID: 4983215
    [No Abstract]   [Full Text] [Related]  

  • 15. Multicenter clinical trial of bortezomib in relapsed/refractory Waldenstrom's macroglobulinemia: results of WMCTG Trial 03-248.
    Treon SP; Hunter ZR; Matous J; Joyce RM; Mannion B; Advani R; Cook D; Songer J; Hill J; Kaden BR; Sharon D; Steiss R; Leleu X; Branagan AR; Badros A
    Clin Cancer Res; 2007 Jun; 13(11):3320-5. PubMed ID: 17545538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The blood coagulation system in patients with Waldenstrom's macroglobulinemia and multiple myeloma].
    Kokeva RA; Zhuravlev VS
    Probl Gematol Pereliv Krovi; 1968 Jun; 13(6):10-5. PubMed ID: 4981865
    [No Abstract]   [Full Text] [Related]  

  • 17. 2-Chlorodeoxyadenosine treatment of Waldenström's macroglobulinemia--the analysis of own experience and the review of literature.
    Lewandowski K; Zaucha JM; Bieniaszewska M; Hałaburda K; Hellmann A
    Med Sci Monit; 2000; 6(4):740-5. PubMed ID: 11208402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marked increase in serum IgM during treatment of Waldenstrom's macroglobulinemia with cladribine.
    Krishna VM; Carey RW; Bloch KJ
    N Engl J Med; 2003 May; 348(20):2045-6. PubMed ID: 12748329
    [No Abstract]   [Full Text] [Related]  

  • 19. Delayed response to fludarabine in lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia.
    Del Giudice I; Matutes E; Osuji N; Parry-Jones N; Swansbury J; Catovsky D
    Haematologica; 2005 Feb; 90(2):268-70. PubMed ID: 15710588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Waldenström's macroglobulinemia.
    McKenna JA
    Clin J Oncol Nurs; 2002; 6(5):283-6. PubMed ID: 12240489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.